Science, institutions, and markets: Developments in the Indian biotechnology sector

被引:11
作者
Bagchi-Sen, Sharmistha [1 ]
Smith, Helen Lawton [2 ]
机构
[1] SUNY Buffalo, Dept Geog, Buffalo, NY 14261 USA
[2] Univ London, Sch Management & Org Psychol, London WC1E 7HX, England
关键词
innovation; biotechnology; pharmaceutical industry; India;
D O I
10.1080/00343400701652800
中图分类号
F [经济];
学科分类号
02 ;
摘要
Science, institutions, and markets: developments in the Indian biotechnology sector, Regional Studies. To be competitive Indian pharmaceutical and biotechnology companies pursue both imitative and innovation-based strategies. Some undertake contractual clinical research from multinationals now that product patents have replaced process patenting. The barriers for innovation are the lack of funds and regulations. Government funding bodies have to reconcile the goals: science for society versus science for profit. The regulatory process (e.g. time taken for drug approvals) is in need of change. In recent years the industry has become more regionalized - states are proactive in promoting bioscience complexes through parks and institutes (e.g. Bangalore and Hyderabad). This has implications for clustered economic development.
引用
收藏
页码:961 / 975
页数:15
相关论文
共 5 条
[1]   Evolutionary economics perspectives on the regional-national-international dimensions of biotechnology innovations [J].
McKelvey, M .
ENVIRONMENT AND PLANNING C-GOVERNMENT AND POLICY, 2004, 22 (02) :179-197
[2]  
METCALFE JS, 1995, CAMBRIDGE J ECON, V19, P25
[3]   Who is interested in biotech? R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms [J].
Ramani, SV .
RESEARCH POLICY, 2002, 31 (03) :381-398
[4]   INTERNATIONAL FACTOR PRICE DIFFERENCES - LEONTIEF WAS RIGHT [J].
TREFLER, D .
JOURNAL OF POLITICAL ECONOMY, 1993, 101 (06) :961-987
[5]   Commercializing knowledge: University science, knowledge capture, and firm performance in biotechnology [J].
Zucker, LG ;
Darby, MR ;
Armstrong, JS .
MANAGEMENT SCIENCE, 2002, 48 (01) :138-153